Author: F. Hoffman-La Roche AG

Posted Date:

March 24, 2026

/C O R R E C T I O N — Roche/

F. Hoffman-La Roche AG

March 24, 2026
Roche launches the cobas eplex respiratory pathogen panel 3, a fast and comprehensive test to help clinicians treat patients with respiratory infections, in CE markets

F. Hoffman-La Roche AG

March 24, 2026
Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer’s disease

F. Hoffman-La Roche AG

March 16, 2026
New survey demonstrates how diabetes limits day-to-day freedom for people around the world and highlights need for predictive tools

F. Hoffman-La Roche AG

March 5, 2026